Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

GANCICLOVIR Drug Profile

« Back to Dashboard

Which patents cover Ganciclovir, and what generic alternatives are available?

Ganciclovir is a drug marketed by Luitpold Pharms Inc, Exela Pharma Scs Llc, Par Sterile Products, Ranbaxy Labs Ltd, Fresenius Kabi Usa, and West-ward Pharms Int. and is included in six NDAs. There is one patent protecting this drug.

The generic ingredient in GANCICLOVIR is ganciclovir . There are twenty-four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ganciclovir profile page.

Summary for Tradename: GANCICLOVIR

Patents:1
Applicants:6
NDAs:6
Suppliers / Packagers: see list5
Bulk Api Vendors: see list89
Clinical Trials: see list25
Patent Applications: see list6,358
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GANCICLOVIR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold Pharms Inc
GANCICLOVIR
ganciclovir sodium
INJECTABLE;INJECTION202624-001Sep 18, 2013APRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
GANCICLOVIR SODIUM
ganciclovir sodium
INJECTABLE;INJECTION076222-001Jul 16, 2003DISCNNoNo► Subscribe► Subscribe
Ranbaxy Labs Ltd
GANCICLOVIR
ganciclovir
CAPSULE;ORAL076457-001Jun 27, 2003DISCNNoNo► Subscribe► Subscribe
Exela Pharma Scs Llc
GANCICLOVIR
ganciclovir
SOLUTION;IV (INFUSION)209347-001Feb 17, 2017RXYesYes9,486,530► SubscribeY ► Subscribe
Par Sterile Products
GANCICLOVIR
ganciclovir sodium
INJECTABLE;INJECTION204950-001Dec 6, 2016APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot